Mylan snaps Agila; Cipla seals Medpro buy in $2bn-plus Indian M&A festival
This article was originally published in Scrip
Executive Summary
It's raining M&A in India. Mylan, the world's third largest generics and specialty pharmaceutical company, has snapped up Strides Arcolab's injectables arm, Agila Specialties while, in an early foray into M&A newbie, Cipla, has sealed a deal to acquire its South African partner firm, Cipla Medpro, for about $512 million.